Results 231 to 240 of about 13,837,613 (303)

Extracellular vesicle lipidomics liquid biopsy reveals systemic and tumor microenvironment metabolic reprogramming in ovarian cancer

Molecular Oncology, EarlyView.
Extracellular vesicle (EV) lipidomic profiling of plasma and ascites from patients with high‐grade serous ovarian cancer and of ovarian cancer cell lines reveals enrichment of triglycerides (TGs), diacylglycerols (DGs), phosphatidylcholine (PCs), sphingomyelins (SMs), reflecting tumor metabolic reprogramming.
Shikha Rani, Dominic Guanzon, Andrew Lai, Katherin Scholz‐Romero, Sarah Reed, Edita Ritmejeryte, Rohan Lourie, Naven Chetty, Kaltin Ferguson, Carlos Salomon   +9 more
wiley   +1 more source

Living with angina: rethinking angina management in ANOCA through lived experience. [PDF]

Front Cardiovasc Med
La S, Brown S, McCall C, Pompa A, Tavella R, Pasupathy S, Beltrame JF.   +6 more
europepmc   +1 more source

A role for eIF5A in translational control of stress‐inducible proteins in multiple myeloma cell lines

Molecular Oncology, EarlyView.
Loss of eIF5A rewires thapsigargin‐mediated endoplasmic reticulum stress responses in multiple myeloma cells by selective translation of mRNA transcripts, consequently dampening thapsigargin‐induced unfolded protein response (UPR) activation and shifting the balance from induction of apoptosis toward cell survival and proliferation.
Demi Both, Ingrid A. M. Derks, Raphaël Vanleyssem, Marine Leclercq, Najla El Hachem, Pierre Close, Eric Eldering, Marco Vincent Haselager   +7 more
wiley   +1 more source

Living Kidney Transplantation in a Patient With End-Stage Kidney Disease Due to Rare Juvenile Nail-Patella-Like Renal Disease Without <i>LMX1B</i> Mutation. [PDF]

Case Rep Transplant
Okabe T, Nakajima Y, Iwatsuki K, Maenosono R, Matsuda T, Tsuchida S, Hanamori T, Fujiwara Y, Nakamori K, Matsunaga T, Yoshikawa Y, Tsujino T, Matsumura H, Nomi H, Ashida A, Azuma H.   +15 more
europepmc   +1 more source

Predictive and prognostic biomarkers of Bacillus Calmette‐Guérin therapy failure in bladder cancer patients: A systematic review

Molecular Oncology, EarlyView.
High‐risk bladder cancer is typically treated with Bacillus Calmette‐Guérin (BCG), but 30–40% of patients relapse. No FDA‐ or CE‐approved biomarkers currently predict or prognosticate BCG failure. We systematically reviewed the literature and identified 72 eligible studies, revealing several promising biomarkers associated with BCG treatment response ...
Rui Ribeiro‐Pereira, Ana Teixeira‐Marques, Rui Freitas, João A Carvalho, Sara Monteiro‐Reis, Giorgio I. Russo, Rui Henrique, Carmen Jerónimo   +7 more
wiley   +1 more source

Public Perceptions of Multiple Long-Term Conditions: An Analysis of Mass Observation Accounts. [PDF]

Health Expect
Bellass S, Scharf T, Bartle V, Sayer AA, Cooper R.   +4 more
europepmc   +1 more source

Safe and efficient intracellular delivery of functional antibodies into cultured neural cells shows a role for Alzheimer's-relevant tau phosphorylation in cell integrity. [PDF]

Front Dement
Viola KL, Chromy BA, Nowar R, Lambert MP, Klein WL.   +4 more
europepmc   +1 more source

Clinical Walking Speed, Free-Living Walking Cadence, and All-Cause Mortality.

JAMA Netw Open
Haddadj R, Danilevicz IM, Rowlands AV, van Hees VT, Landré B, Le Faucheur A, Singh-Manoux A, Mork PJ, Sabia S.   +8 more
europepmc   +1 more source